IBEX Limited (“ibex”) (Nasdaq: IBEX), a global leader in outsourced business services and AI-powered customer experience solutions, today announced that its Board of Directors has authorized a share ...
Hosted on MSN
CDW expands share repurchase program by $1B
Buyback boost: CDW authorized an extra $1B in share repurchases, adding to $484M left from its prior program as of March 31, 2026. Efficiency targets: The company plans $100M-$200M in run-rate ...
The industrial giant launched the buyback program of up to five years as it posted higher second-quarter revenue in its ...
Q1 2026 earnings call: revenue and guidance, Casgevy royalties, DTx/SeQure growth drivers, and $10M buyback—read key takeaways.
Arrow Electronics' board approved a new share repurchase program of up to $1 billion. The authorization replaces the company's existing share repurchase program. Last week the company reported $9.47 ...
The creative software giant is using its enormous cash flow to scoop up its own beaten-down shares -- and the stock still ...
CAPE TOWN, South Africa () - Leatt Corporation (OTCQB: LEAT), a leading developer and marketer of head-to-toe protective equipment for MOTO, MTB, ADV, and a wide range of extreme and high-velocity ...
Barrick Mining rose to two-month highs after handily beating expectations for Q1 adjusted earnings and revenues, helped by ...
Luckin Coffee (OTCPK:LKNC.Y) has authorized a share repurchase program of up to US$300 million. The buybacks are scheduled to ...
STAMFORD, Conn., April 16, 2026 /PRNewswire/ -- Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) ("Curaleaf" or the "Company"), a leading international provider of consumer cannabis products, has ...
As of April 9, 2026 the Company held in treasury No. 17,494,660 common shares, net of shares assigned under the Company’s equity incentive plan, corresponding to 9.02% of the total issued common ...
BERKELEY HEIGHTS, N.J., Feb. 02, 2026 (GLOBE NEWSWIRE) -- CorMedix Therapeutics (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results